Tricia L. May-Dracka

发表

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases

S. McLeod, R. Tommasi, M. Sacco, 2020, Journal of medicinal chemistry.

CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling

Kejie Li, A. Buckler, E. Cahir-McFarland, 2018, Science Signaling.

Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens.

Dean G. Brown, R. Tommasi, Tricia L May-Dracka, 2014, Journal of medicinal chemistry.

Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System Penetrance.

I. Enyedy, M. Kaliszczak, Mark W Kankel, 2022, ACS medicinal chemistry letters.

Stereocontrolled enantioselective total synthesis of the [2+2] quadrigemine alkaloids.

Stephen M. Canham, L. Overman, Sangkil Nam, 2015, Tetrahedron.

New natural products as new leads for antibacterial drug discovery.

Troy Lister, Dean G. Brown, T. Lister, 2014, Bioorganic & medicinal chemistry letters.

Human PLD structures enable drug design and characterization of isoenzyme selectivity

I. Enyedy, Michael L. Cullivan, J. Santoro, 2020, Nature Chemical Biology.

Germinal‐center kinase‐like kinase co‐crystal structure reveals a swapped activation loop and C‐terminal extension

C. Lukacs, L. Silvian, J. Lyssikatos, 2017, Protein science : a publication of the Protein Society.

New Natural Products as New Leads for Antibacterial Drug Discovery

Dean G. Brown, T. Lister, Tricia L May-Dracka, 2014 .

Structure of compound 3 (ML299) bound human Phospholipase D2 catalytic domain

J. Chodaparambil, Tricia L. May-Dracka, C. Metrick, 2020 .